SIGA Announces BARDA Exercise of Contract Options Valued at $101.3 Million for the Procurement of Oral TPOXX®

NEXT STORY
BeiGene Announces Clinical Data to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting
PREV STORY
Apellis Pharmaceuticals Reports First Quarter 2020 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Oncology Venture erhåller europeiskt patent för sin AI-drivna metod vilken kan identifiera patienter som svarar på behandling med LiPlaCis

author_avatar
NASDAQ Market News

Karyopharm Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress

author_avatar
NASDAQ Market News

Landmark ADMIRAL Study Publication with CareDx’s AlloSure Kidney is the First Long-Term Multicenter Prospective Clinical Validation for Routine Organ Transplant Surveillance

author_avatar
NASDAQ Market News